EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Evaluation of antibiofilm agents for treatment of cystic fibrosis‐related chronic rhinosinusitis

Saartje Uyttebroek iD, Lieven Dupont, Jeroen Wagemans, Rob Lavigne, Maya Merabishvili, Tom Coenye, Laura Van Gerven

International Forum of Allergy & Rhinology · 2025

DOI: 10.1002/alr.23441 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Forum of Allergy & Rhinology, 2025. Verfasst von Saartje Uyttebroek und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, Head and Neck Surgery, UZ Leuven, Leuven, Belgium. Hauptthemen laut MEDLINE: Biofilms, Sinusitis, Cystic Fibrosis, Rhinitis. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: KU Leuven, Research Foundation Flanders, Fonds Wetenschappelijk Onderzoek.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Key points Treatment of cystic fibrosis‐related chronic rhinosinusitis should target sinonasal biofilms. NaHCO 3 salts with/without xylitol have limited antibiofilm properties, whereas rhDNAse has not. Phage effectivity varies and depends on the phage and the combination with antibiotics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiofilmsSinusitisCystic FibrosisRhinitisAnti-Bacterial AgentsHumansChronic DiseaseDeoxyribonuclease IPhage TherapyXylitolRhinosinusitis

Stichwörter der Autor:innen

CRSbacteriophagesbiofilmchronic rhinosinusitisphagetreatment

Substanzen

Anti-Bacterial AgentsDeoxyribonuclease IXylitol

Autor:innen und Institutionen

  • Department of Otorhinolaryngology, Head and Neck Surgery, UZ Leuven, Leuven, Belgium.
  • Department of Neurosciences, Experimental Otorhinolaryngology, Rhinology Research, KU Leuven, Leuven, Belgium.
  • Department of Pneumology, UZ Leuven, Leuven, Belgium.
  • Department of Chronic Diseases and Metabolism, Respiratory Diseases and Thoracic Surgery, KU Leuven, Leuven, Belgium.
  • Department of Biosystems, Laboratory of Gene Technology, KU Leuven, Leuven, Belgium.
  • Laboratory for Molecular and Cellular Technology, Queen Astrid Military Hospital, Neder-over-Heembeek, Belgium.

ORCID-Profile: Saartje Uyttebroek

Förderung

  • KU Leuven
  • Research Foundation Flanders
  • Fonds Wetenschappelijk Onderzoek

Zitieren

APA

Uyttebroek, S., Dupont, L., Wagemans, J., Lavigne, R., Merabishvili, M., Coenye, T., & Van Gerven, L. (2025). Evaluation of antibiofilm agents for treatment of cystic fibrosis‐related chronic rhinosinusitis. International Forum of Allergy & Rhinology. https://doi.org/10.1002/alr.23441

Vancouver

Uyttebroek S, Dupont L, Wagemans J, Lavigne R, Merabishvili M, Coenye T, et al. Evaluation of antibiofilm agents for treatment of cystic fibrosis‐related chronic rhinosinusitis. International Forum of Allergy & Rhinology. 2025. doi:10.1002/alr.23441

BibTeX
@article{Uyttebroek2025,
  author = {Uyttebroek, Saartje and Dupont, Lieven and Wagemans, Jeroen and Lavigne, Rob and Merabishvili, Maya and Coenye, Tom and Van Gerven, Laura},
  title = {Evaluation of antibiofilm agents for treatment of cystic fibrosis‐related chronic rhinosinusitis},
  journal = {International Forum of Allergy & Rhinology},
  year = {2025},
  doi = {10.1002/alr.23441}
}
Kostenlos starten →